POST Online Media Lite Edition



 

Merck does not want to sell $1 billion consumer health business

Staff writer |
Merck KGaA plans to keep hold of its consumer healthcare unit, pledging to develop a business that is expected to generate 2014 sales of $1 billion.

Article continues below






The non-prescription market has seen a wave of consolidation this year but the family-controlled company says it has no intention of quitting.

"We really want to stick to that business. Our strategy is a pure growth strategy and by the end of this year we will hopefully hit the $1 billion sales mark," Uta Kemmerich-Keil, chief executive of Merck Consumer Health, said during a media briefing in London.

Kemmerich-Keil said she aimed to have at least three leading brands with a minimum 3 percent market share in key target countries, which include a number of emerging markets, like Brazil, where demand for self-medication is growing strongly.

While securing strong positions in local markets could involve small bolt-on acquisitions or licensing deals, she sees no need for large-scale acquisitions.

"OTC is a local play, so you need to make sure in the markets you are in that you are strong .It's not important how big the overall business is."


What to read next

Sigma-Aldrich and Merck KGaA have EU approval for acquisition
Sigma-Aldrich good to be bought by Merck KGaA
Merck solves Vioxx class action, will pay $830 million